CyberKnife is a robotic radiation therapy system that delivers highly focused beams of radiation to tumors from hundreds of unique angles, destroying cancer cells while sparing surrounding healthy tissue. Unlike conventional radiation machines that rotate in a single plane, CyberKnife mounts a compact radiation source onto a robotic arm that can move freely in six directions, allowing it to aim at a tumor from virtually any position around the body.
The Robotic Arm and Radiation Source
At the core of CyberKnife is a lightweight linear accelerator, the device that actually generates the radiation beam, attached to an industrial robotic arm. This arm has six degrees of freedom, meaning it can move up, down, left, right, forward, backward, and rotate along multiple axes. A conventional radiation machine is bolted to a large circular gantry that only rotates around the patient in one plane, like a wheel spinning around an axle. CyberKnife’s robotic arm breaks free of that constraint entirely.
Because the arm can position itself so flexibly, treatments are what physicists call “non-isocentric.” In plain terms, the beams don’t all have to converge through a single fixed point. The system can shape the radiation dose to match irregular tumor shapes by directing beams from dozens or even hundreds of different angles during a single session. Each individual beam is relatively weak, but where they all overlap at the tumor site, the combined dose is powerful enough to damage cancer cells’ ability to reproduce.
How It Tracks a Moving Target
One of CyberKnife’s most important features is its ability to follow a tumor that moves while the patient breathes. This matters most for tumors in the lungs, liver, and pancreas, where every breath shifts the target by several millimeters.
The system uses a real-time tracking technology called Synchrony. Small markers placed on the patient’s chest rise and fall with each breath. At the same time, the system takes rapid X-ray images to see exactly where the tumor is inside the body. It correlates the external breathing pattern with the internal tumor position, building a predictive model of the motion. The robotic arm then continuously adjusts, moving the radiation beam so it stays locked on the tumor throughout treatment. This means patients can breathe normally rather than holding their breath or being compressed into a breathing restriction device.
Tracking Methods for Different Body Sites
CyberKnife uses different tracking approaches depending on where the tumor is located. For brain and spine tumors, the system tracks the bony anatomy of the skull or vertebrae directly using X-ray images, no additional preparation needed. For lung tumors, a specialized tracking mode can follow the tumor itself without any implanted markers, as long as the tumor is visible enough on X-ray against the surrounding air-filled lung tissue.
For tumors in soft tissue areas like the prostate, liver, or pancreas, the system needs a reference point it can see on X-ray. This is where fiducial markers come in: tiny gold seeds, each about the size of a grain of rice, implanted in or near the tumor before treatment begins. At least three markers are needed so the system can track not just the tumor’s position but also any rotation. Doctors typically place four to account for the possibility that one might shift or become difficult to visualize. The implantation is a minor outpatient procedure done days or weeks before the first radiation session.
No Head Frame Required
For brain tumors, CyberKnife offers a significant comfort advantage over an older technology called Gamma Knife. Gamma Knife requires a rigid metal frame to be screwed into the patient’s skull to hold the head perfectly still during treatment. CyberKnife replaces this with a simple mesh mask that fits snugly over the face. The system compensates for any small movements by continuously imaging the skull’s position and adjusting the beam in real time. This frameless approach also makes it practical to split brain treatments across multiple sessions rather than delivering the entire dose in one sitting.
Gamma Knife uses 201 small radioactive sources arranged in a helmet-like configuration, all focused on a single point inside the skull. It works well for brain tumors but cannot treat anything below the neck. CyberKnife’s robotic design allows it to reach tumors virtually anywhere in the body.
What Treatment Feels Like
CyberKnife treatments are completely painless during the session itself. You lie on a treatment table, and the robotic arm moves around you while delivering radiation. There’s no cutting, no anesthesia, and no sensation from the beams. Sessions typically last between 30 and 90 minutes, and most treatment plans call for one to five daily sessions total. This is dramatically fewer visits than conventional radiation therapy, which often requires 25 to 40 sessions spread over many weeks.
During the session, X-ray cameras mounted in the ceiling and floor take images every few seconds, and the system automatically corrects the beam’s aim if you shift slightly. You don’t need to stay perfectly motionless, though staying as still as reasonably possible helps keep sessions efficient. Most people drive themselves home afterward and return to normal activities the same day.
Common Side Effects
Because CyberKnife concentrates radiation tightly on the tumor, side effects tend to be milder than with broader radiation techniques, but they aren’t absent. The specific side effects depend heavily on which part of the body is being treated.
For prostate treatments, urinary symptoms are the most commonly reported issue. The radiation can irritate the bladder and urethra, causing increased urgency, frequency, or a weak stream. These symptoms typically develop in the days or weeks following treatment and gradually improve, though some patients need medication to manage urinary flow during recovery. Rectal irritation is also possible, though newer techniques using a gel spacer between the prostate and rectum have reduced this risk significantly.
For brain treatments, fatigue and mild headaches are common in the weeks afterward. Swelling around the treated area can occur and may temporarily worsen neurological symptoms before they improve. For lung and liver tumors, fatigue is the most frequent complaint, sometimes accompanied by mild nausea.
What CyberKnife Treats
CyberKnife is used for both cancerous and noncancerous conditions. In the brain, it treats metastases from cancers that have spread from elsewhere in the body, as well as primary brain tumors, meningiomas, pituitary tumors, and spinal cord tumors. It’s also used for a noncancerous condition called trigeminal neuralgia, a nerve disorder that causes severe facial pain.
Outside the brain, CyberKnife is widely used for early-stage lung cancer (particularly in patients who aren’t good candidates for surgery), prostate cancer, liver tumors (both primary and metastatic), pancreatic cancer, and kidney tumors. It can also treat tumors along the spine where conventional surgery would be risky due to the proximity of the spinal cord. The system’s precision, often within a millimeter of the intended target, makes it especially valuable when tumors sit close to critical structures that can’t tolerate stray radiation.